NASDAQ
BTSG
Last Price
US $60.73
KEY FIGURES
MKT CAP
$11.9B
EPS
TTM$1.43
EPS Growth (1Y)
-1029.49%
PEG
TTM0.88x
P/E
TTM42.55x
P/S
TTM0.87x
YIELD
-
GROWTH (5Y CAGR)
Revenue
18.27%
EBITDA
Base Cash Flow Valuation (DCF)
Fair Value
Market $60.73
-63.82%
Default assumptions
Base EBITDA Valuation
Fair Value
Market $60.73
-96.06%
Valuation
Financial
Performance
Cash flow to debt coverage
BrightSpring Health Services, Inc. Common Stock cash flow to debt ratio of 18.11% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
BrightSpring Health Services, Inc. Common Stock's free cash flow has increased 790.75% from $-57.14M last year to $394.69M, signaling increasing performance
Debt-to-equity ratio
BrightSpring Health Services, Inc. Common Stock's debt to equity ratio is 1.17, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
BrightSpring Health Services, Inc. Common Stock's debt has decreased relative to shareholder equity from 1.76 last year to 1.17 today, signaling strengthened financials
Net debt to EBITDA
BrightSpring Health Services, Inc. Common Stock has a net debt to EBITDA ratio of 5.70x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
BrightSpring Health Services, Inc. Common Stock's interest coverage ratio of 3.14 indicates that earnings with margin can cover interest payments on company debt
Profit margin growth
BrightSpring Health Services, Inc. Common Stock's profit margin has increased (1.38K%) in the last year from -0.16% to 2.05%, signaling increasing performance
Current ratio
BrightSpring Health Services, Inc. Common Stock's short-term assets of $2.89B exceed its short-term liabilities of $1.85B
Return on assets
BrightSpring Health Services, Inc. Common Stock's return on assets of 4.91% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
BrightSpring Health Services, Inc. Common Stock's return on equity of 15.23%, is higher than 15.00%, indicating good performance
Earnings quality
BrightSpring Health Services, Inc. Common Stock's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
BrightSpring Health Services, Inc. Common Stock has insufficient public price history to evaluate earnings stability.
Positive free cash flow
BrightSpring Health Services, Inc. Common Stock has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
BrightSpring Health Services, Inc. Common Stock has a free cash flow yield of 3.31%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
BrightSpring Health Services, Inc. Common Stock's yearly earnings has increased 1.16K% since last year from $-18.06M to $190.67M, signaling increasing performance
Revenue growth
BrightSpring Health Services, Inc. Common Stock's yearly revenue has increased 14.59% since last year from $11.27B to $12.91B, signaling increasing performance
Return on invested capital
ROIC 8.87% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
3-year revenue CAGR
BrightSpring Health Services, Inc. Common Stock's 3-year revenue CAGR of 18.69% is positive, indicating growing revenue over the past 3 years
Revenue consistency
BrightSpring Health Services, Inc. Common Stock has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
BrightSpring Health Services, Inc. Common Stock has insufficient public price history to evaluate ROE consistency.
Base Cash Flow Valuation (DCF)
BrightSpring Health Services, Inc. Common Stock is overvalued relative to its fair value price of 21.97 based on Base Cash Flow Valuation (DCF) model
Earnings yield (TTM)
BrightSpring Health Services, Inc. Common Stock has an earnings yield of 2.35%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Base EBITDA Valuation
BrightSpring Health Services, Inc. Common Stock is overvalued relative to its fair value price of 2.39 based on Base EBITDA Valuation model
EV/EBITDA (FY)
BrightSpring Health Services, Inc. Common Stock has an EV/EBITDA ratio of 31.64x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
BrightSpring Health Services, Inc. Common Stock has a PEG-ratio under 1 which is considered undervalued
Price-to-book ratio (FY)
BrightSpring Health Services, Inc. Common Stock has a price-to-book ratio of 6.08x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
BrightSpring Health Services, Inc. Common Stock has a price-to-sales ratio of 0.87x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
15.23%
Return on equity
ROIC: 8.87%
Valuation History
42.2X
Price to Earnings
EV/EBITDA: 21.5X
Cash flow
Profit margin
5.80%
Cash flow
18.25%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.